Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria – A double-blind, placebo-controlled randomized trial

M. Rodríguez-Morán; G. González-González; M.V. Bermúdez-Barba; C.E. Medina de la Garza; H.E. Tamez-Pérez; F.J. Martínez-Martínez; F. Guerrero-Romero

doi:10.5414/cnp66003

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria A double-blind, placebo-controlled randomized trial

Clinical Nephrology ◽

10.5414/cnp66003 ◽

2006 ◽

Vol 66 (07) ◽

pp. 3-10 ◽

Cited By ~ 28

Author(s):

M. Rodríguez-Morán ◽

G. González-González ◽

M.V. Bermúdez-Barba ◽

C.E. Medina de la Garza ◽

H.E. Tamez-Pérez ◽

...

Keyword(s):

Randomized Trial ◽

Urinary Protein Excretion ◽

Urinary Protein ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Protein Excretion ◽

Type 2 Diabetic

Download Full-text

Variations of urinary protein excretion and α1-antitrypsin molecular size by glycemic control in type 2 diabetic patients

Journal of Electrophoresis ◽

10.2198/jelectroph.55.13 ◽

2011 ◽

Vol 55 (1) ◽

pp. 13-22

Author(s):

Mayuka Goya ◽

Mie Arai ◽

Kenjiro Yamanaka ◽

Yoshinori Kanai ◽

Kiyoko Shiba ◽

...

Keyword(s):

Glycemic Control ◽

Molecular Size ◽

Urinary Protein Excretion ◽

Urinary Protein ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Protein Excretion ◽

Type 2 Diabetic

Download Full-text

The effects of vitamin D and curcuminoids supplementation on anthropometric measurements and blood pressure in type 2 diabetic patients with coexisting hypovitaminosis D: A double-blind, placebo-controlled randomized clinical trial

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2020.02.017 ◽

2020 ◽

Vol 37 ◽

pp. 178-186

Author(s):

Shirin Ebrahimkhani ◽

Saeid Ghavamzadeh ◽

Alireza Mehdizadeh

Keyword(s):

Blood Pressure ◽

Clinical Trial ◽

Vitamin D ◽

Hypovitaminosis D ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Type 2 Diabetic

Download Full-text

Effect of Chromium Dinicocysteinate Supplementation on Circulating Levels of Insulin, Tnf-α, Oxidative Stress and Insulin Resistance in Type 2 Diabetic Patients: Randomized, Double-Blind, Placebo-Controlled Study

Journal of the Academy of Nutrition and Dietetics ◽

10.1016/j.jand.2012.06.123 ◽

2012 ◽

Vol 112 (9) ◽

pp. A34 ◽

Cited By ~ 1

Author(s):

F. Lau ◽

S.K. Jain ◽

G. Kahlon ◽

L. Moorehead ◽

G. Caldito ◽

...

Keyword(s):

Oxidative Stress ◽

Controlled Study ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Tnf Α ◽

Circulating Levels ◽

Type 2 Diabetic

Download Full-text

Irbesartan Reduces the Albumin Excretion Rate in Microalbuminuric Type 2 Diabetic Patients Independently of Hypertension: A randomized double-blind placebo-controlled crossover study

Diabetes Care ◽

10.2337/diacare.25.11.1909 ◽

2002 ◽

Vol 25 (11) ◽

pp. 1909-1913 ◽

Cited By ~ 37

Author(s):

F. C. Sasso ◽

O. Carbonara ◽

M. Persico ◽

D. Iafusco ◽

T. Salvatore ◽

...

Keyword(s):

Crossover Study ◽

Excretion Rate ◽

Albumin Excretion Rate ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Albumin Excretion ◽

Type 2 Diabetic

Download Full-text

Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients: a randomized, double-blind, placebo-controlled trial

Nutrition and Diabetes ◽

10.1038/nutd.2017.8 ◽

2017 ◽

Vol 7 (4) ◽

pp. e259-e259 ◽

Cited By ~ 26

Author(s):

M J Zibaeenezhad ◽

P Farhadi ◽

A Attar ◽

A Mosleh ◽

F Amirmoezi ◽

...

Keyword(s):

Controlled Trial ◽

Lipid Profiles ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Walnut Oil ◽

Double Blind Placebo ◽

Type 2 Diabetic

Download Full-text

Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Complementary Therapies in Medicine ◽

10.1016/j.ctim.2013.07.003 ◽

2013 ◽

Vol 21 (5) ◽

pp. 447-452 ◽

Cited By ~ 26

Author(s):

Hassan Fallah Huseini ◽

Shirin Hasani-Rnjbar ◽

Neda Nayebi ◽

Ramin Heshmat ◽

Farahnaz Khaliqi Sigaroodi ◽

...

Keyword(s):

Clinical Trial ◽

Controlled Clinical Trial ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Fruit Extract ◽

Double Blind ◽

Double Blind Placebo ◽

Capparis Spinosa ◽

Type 2 Diabetic

Download Full-text

Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial

European Journal of Nutrition ◽

10.1007/s00394-016-1352-4 ◽

2016 ◽

Vol 56 (7) ◽

pp. 2415-2422 ◽

Cited By ~ 16

Author(s):

Feng Wang ◽

Yanyan Wang ◽

Yan Zhu ◽

Xiaosong Liu ◽

Hui Xia ◽

...

Keyword(s):

Fatty Acids ◽

Glycemic Control ◽

Fish Oil ◽

Controlled Trial ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Type 2 Diabetic

Download Full-text

Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control, Glucose Metabolism and Lipid Profile in Hypertensive, Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled 12-Month Study

Hypertension Research ◽

10.1291/hypres.27.457 ◽

2004 ◽

Vol 27 (7) ◽

pp. 457-464 ◽

Cited By ~ 114

Author(s):

Giuseppe DEROSA ◽

Pietro D RAGONESI ◽

Amedeo MUGELLINI ◽

Leonardina CICCARELLI ◽

Roberto FOGARI

Keyword(s):

Blood Pressure ◽

Glucose Metabolism ◽

Lipid Profile ◽

Pressure Control ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Type 2 Diabetic

Download Full-text

Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial

Pharmacological Research ◽

10.1016/j.phrs.2016.08.010 ◽

2016 ◽

Vol 111 ◽

pp. 896-905 ◽

Cited By ~ 63

Author(s):

S. Bo ◽

V. Ponzo ◽

G. Ciccone ◽

A. Evangelista ◽

F. Saba ◽

...

Keyword(s):

Controlled Trial ◽

Diabetic Patients ◽

Measurable Effect ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Type 2 Diabetic

Download Full-text

Lack of interference of aspirin in HbA1c measured by ion-exchange HPLC in type 2 diabetic patients: A randomized, double-blind, placebo-controlled study

Clinica Chimica Acta ◽

10.1016/j.cca.2008.01.029 ◽

2008 ◽

Vol 391 (1-2) ◽

pp. 120-122 ◽

Cited By ~ 4

Author(s):

Eduardo G. Camargo ◽

Renata O. Pedrini ◽

Jorge L. Gross ◽

Joiza L. Camargo ◽

Sandra P. Silveiro

Keyword(s):

Ion Exchange ◽

Controlled Study ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Ion Exchange Hplc ◽

Type 2 Diabetic

Download Full-text

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria  A double-blind, placebo-controlled randomized trial

Variations of urinary protein excretion and α1-antitrypsin molecular size by glycemic control in type 2 diabetic patients

The effects of vitamin D and curcuminoids supplementation on anthropometric measurements and blood pressure in type 2 diabetic patients with coexisting hypovitaminosis D: A double-blind, placebo-controlled randomized clinical trial

Effect of Chromium Dinicocysteinate Supplementation on Circulating Levels of Insulin, Tnf-α, Oxidative Stress and Insulin Resistance in Type 2 Diabetic Patients: Randomized, Double-Blind, Placebo-Controlled Study

Irbesartan Reduces the Albumin Excretion Rate in Microalbuminuric Type 2 Diabetic Patients Independently of Hypertension: A randomized double-blind placebo-controlled crossover study

Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients: a randomized, double-blind, placebo-controlled trial

Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial

Effects of Telmisartan Compared with Eprosartan on Blood Pressure Control, Glucose Metabolism and Lipid Profile in Hypertensive, Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled 12-Month Study

Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial

Lack of interference of aspirin in HbA1c measured by ion-exchange HPLC in type 2 diabetic patients: A randomized, double-blind, placebo-controlled study

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria A double-blind, placebo-controlled randomized trial